Table 3.
Night-time progression of QTc: mixed, linear regression analysis.
Dependent variable: QTc, ms | Coefficient | SE | 95% CI | P |
---|---|---|---|---|
490 m (ref) | ||||
2,048 m placebo vs. 490 m | 4.7 | 0.1 | 4.5 to 4.9 | <0.001 |
2,048 m NOT vs. 490 m | 1.8 | 0.1 | 1.6 to 2.0 | <0.001 |
Night-time | ||||
First 10 min (ref) | ||||
11–70 min | 3.6 | 0.3 | 3.0 to 4.2 | <0.001 |
71–130 min | 4.0 | 0.3 | 3.4 to 4.6 | <0.001 |
131–190 min | 3.3 | 0.3 | 2.6 to 3.9 | <0.001 |
191–250 min | 3.2 | 0.3 | 2.6 to 3.8 | <0.001 |
251–310 min | 2.8 | 0.3 | 2.2 to 3.4 | <0.001 |
311–370 min | 0.9 | 0.3 | 0.3 to 1.5 | 0.003 |
371–430 min | 0.1 | 0.3 | −0.5 to 0.7 | 0.739 |
431–480 min | −1.0 | 0.3 | −1.6 to −0.4 | 0.002 |
Age, years | 0.9 | 1.4 | −1.8 to 3.6 | 0.504 |
Sex, male vs. female | −17.2 | 15.5 | −47.6 to 13.2 | 0.267 |
FEV1 %pred. at 490 m | −0.3 | 0.6 | −1.5 to 0.9 | 0.664 |
Intercept | 374.4 | 110.3 | 158.2 to 590.5 | 0.001 |
The dependent variable QTc was averaged over consecutive 1-min intervals throughout the nights, and a total of 31,589 1-min intervals were included in this mixed, linear regression analysis.
FEV1, forced expiratory volume in the first second of expiration.